propose

# RESEARCH BRIEF: h-var-a4975bdd96
## Closed-Loop Transcranial Focused Ultrasound to Restore Hippocampal Gamma Oscillations via Cholecystokinin Interneuron Neuromodulation in Alzheimer's Disease

---

## CONTEXTUAL FRAMEWORK

**Central Hypothesis:** Non-invasive, closed-loop TFUS targeting CCK-expressing interneurons can selectively restore hippocampus-dependent gamma oscillations, thereby rescuing synaptic plasticity deficits and cognitive function in Alzheimer's disease (AD) through amyloid-independent and amyloid-dependent mechanisms.

**Knowledge Gaps:**
- Whether CCK interneurons (distinct from parvalbumin [PV] interneurons) represent viable gamma restoration targets in AD
- Mechanistic transduction pathway linking ultrasonic mechanical energy to CCK interneuron membrane excitability
- Optimal closed-loop parameters for adaptive stimulation based on real-time gamma detection
- Integration of CCK interneuron-specific modulation with existing AD therapeutic frameworks

---

## HYPOTHESES

### H1: CCK Interneurons as Primary Gamma Restoration Targets

**Title:** Cholecystokinin-expressing basket cells mediate gamma frequency hypersynchrony restoration upon TFUS stimulation

**Mechanism:** TFUS mechanical pressure waves transiently open mechanosensitive ion channels (TREK-1, TRPV4) on CCK-positive hippocampal interneurons, producing graded membrane depolarization that enhances their firing precision during theta-gamma coupling. CCK interneurons possess unique phasic release properties that, when recruited, can generate gamma oscillations sufficient to entrain local pyramidal cell ensembles.

**Target Gene/Protein/Pathway:**
- *CCK* (cholecystokinin peptide) — interneuron identity marker
- TREK-1 (KCNK2) — mechanosensitive potassium channel
- TRPV4 — mechanically-gated calcium channel
- Cav3.1/3.3 (CACNA1G/1G3) — T-type calcium channels supporting rebound excitation

**Supporting Evidence:**
- CCK basket cells generate precisely timed inhibition controlling pyramidal cell synchronization (PMID: 17003921)
- Mechanical activation of TREK-1 channels modulates neuronal excitability (PMID: 12529375)
- Hippocampal gamma oscillations are impaired in 5xFAD mice before plaque deposition (PMID: 31704477)
- CCK-Cre transgenic mouse lines enable cell-type-specific targeting (PMID: 16702535)

**Predicted Experiment:** Whole-cell patch clamp recordings from CCK-Cre;tdTomato neurons in acute hippocampal slices during simulated TFUS (radiation pressure via piezoelectric actuator). Measure: resting membrane potential shift, action potential fidelity during gamma-frequency current injection, synaptic release probability changes. Control with TREK-1 blocker spadin or TRPV4 antagonist HC-067047.

**Confidence:** 0.72

---

### H2: Closed-Loop Gamma Entrainment Reduces Amyloid-β via Perineuronal Net Modification

**Title:** Restored gamma oscillations decrease hippocampal amyloid-β accumulation through CCK interneuron-mediated perineuronal net degradation

**Mechanism:** CCK interneuron-mediated gamma entrainment (40 Hz) activates intracellular calcium signaling cascades (CaMKIIα, calcineurin) in surrounding astrocytes, triggering matrix metalloproteinase-9 (MMP-9) release that degrades chondroitin sulfate proteoglycans in the perineuronal net (PNN). PNN reduction around CCK interneurons creates a permissive feedback loop for enhanced gamma generation and reduced local amyloid aggregation due to increased interstitial fluid clearance.

**Target Gene/Protein/Pathway:**
- CaMKIIα (CAMK2A) — calcium/calmodulin-dependent kinase
- MMP-9 (MMP9) — matrix metalloproteinase-9
- CSPG (aggrecan, brevican) — perineuronal net components
- Aβ degrading enzymes (IDE, neprilysin)

**Supporting Evidence:**
- 40 Hz gamma entrainment reduces amyloid-β and tau in AD mouse models (PMID: 29463761, 31337704)
- Perineuronal nets restrict plasticity and may impede amyloid clearance (PMID: 24658603)
- CCK interneurons are frequently enwrapped by PNNs in hippocampus (PMID: 25330476)
- Astrocytic CaMKIIα activation triggers MMP secretion (PMID: 21884904)

**Predicted Experiment:** 5xFAD or APP/PS1 mice receive 7-day closed-loop TFUS (adaptive stimulation locked to real-time LFP gamma power). Measure via:
1. In vivo Min6 amyloid sensor imaging pre/post stimulation
2. ELISA for soluble Aβ40/42 in hippocampal homogenates
3. MMP-9 activity assay (zymography) from acute brain slices
4. PNN quantification (WFA staining) around CCK+ neurons (colocalized via ISH)

**Confidence:** 0.65

---

### H3: Closed-Loop TFUS Rescues CCK Interneuron Dysfunction via Mitochondrial Dynamics Restoration

**Title:** TFUS neuromodulation restores hippocampal CCK interneuron metabolic integrity through MCKAT1-mediated mitochondrial trafficking

**Mechanism:** In AD, mitochondrial dysfunction selectively impairs CCK interneurons due to their high metabolic demands during sustained gamma-frequency firing. TFUS mechanical stimulation activates Piezo1 channel-mediated calcium influx, which via calcineurin activation promotes dephosphorylation of Drp1 (S637), shifting mitochondrial fission/fusion balance toward fusion. Restored mitochondrial dynamics enhance ATP production, normalizing CCK interneuron firing fidelity and gamma oscillation stability.

**Target Gene/Protein/Pathway:**
- Piezo1 (PIEZO1) — mechanosensitive calcium channel
- Drp1 (DNM1L) — dynamin-related protein 1 (fission regulator)
- OPA1 (OPA1) — inner membrane GTPase (fusion)
- MFN2 (MFN2) — mitofusin 2 (outer membrane fusion)
- Calcineurin (PPP3CA) — calcium-dependent phosphatase

**Supporting Evidence:**
- Mitochondrial dysfunction in AD selectively affects GABAergic interneurons (PMID: 26997651)
- Piezo1 activation by mechanical force induces calcium-dependent signaling (PMID: 32139554)
- Drp1 S637 dephosphorylation promotes mitochondrial fusion (PMID: 16839817)
- CCK interneurons exhibit enhanced vulnerability in AD postmortem tissue (PMID: 33218539)

**Predicted Experiment:** CCK-Cre;MitoTimer mice (mitochondrial redox state reporter) receive single-dose TFUS (0.5 MPa, 500 kHz, 10 ms bursts, 20 Hz pulse repetition). Assess:
1. Real-time mitochondrial morphology changes via two-photon imaging
2. Seahorse XF assay for oxygen consumption rate in FACS-isolated CCK+ cells
3. Western blot for p-Drp1(S637)/total Drp1 ratio at 0, 30, 60, 120 min post-TFUS
4. In vitro Aβ42 oligomer pretreatment to model AD metabolic stress

**Confidence:** 0.61

---

### H4: CCK Interneuron-Specific Entrainment Rescues Hippocampal Ripple-Gamma Coupling

**Title:** Closed-loop TFUS targeting CCK interneurons restores ripple-associated gamma oscillations during memory consolidation

**Mechanism:** Sharp-wave ripples (SWRs; 150-250 Hz) nested within gamma oscillations encode memory engrams critical for hippocampal-dependent learning. CCK interneurons specifically modulate SWR-γ coupling through differential expression of cannabinoid receptor type 1 (CB1). TFUS-mediated CCK activation restores this coupling, enabling proper reinstatement of place cells and memory consolidation during NREM sleep.

**Target Gene/Protein/Pathway:**
- CB1 (CNR1) — cannabinoid receptor 1 on CCK terminals
- NPY (neuropeptide Y) — co-released with CCK
- HCN1 (HCN1) — hyperpolarization-activated cyclic nucleotide-gated channel
- Kv3.1 (KCNC1) — potassium channel enabling fast-spiking phenotype

**Supporting Evidence:**
- SWR-γ coupling correlates with memory performance in humans and rodents (PMID: 29463761)
- CB1-expressing interneurons (including CCK) regulate SWR timing (PMID: 24523693)
- 40 Hz stimulation enhances SWR events during NREM sleep (PMID: 33050941)
- CCK-CB1 interneurons are functionally distinct from PV interneurons in rhythm generation (PMID: 28607508)

**Predicted Experiment:** Chronic closed-loop TFUS in aged 3xTg mice during NREM sleep (EEG/EMG-defined states). Primary outcome: SWR-γ coupling coefficient (measured via phase-amplitude coupling analysis) in hippocampal CA1 LFP. Secondary: object location memory test (24 hr delay) and immediate early gene (c-Fos) tagging of activated engram cells. Control: non-closed-loop continuous TFUS, chemogenetic (hM3Dq) CCK activation without ultrasound.

**Confidence:** 0.68

---

### H5: Closed-Loop Gamma Restoration Ameliorrates Tau Pathology via Glymphatic Clearance

**Title:** CCK interneuron-mediated gamma oscillations enhance glymphatic cerebrospinal fluid influx, reducing hippocampal tau propagation

**Mechanism:** Gamma frequency firing of CCK interneurons produces rhythmic vasoconstriction/dilation of penetrating arterioles via neuropeptide release (CGRP, substance P), driving glymphatic cerebrospinal fluid (CSF) influx through perivascular spaces. This enhanced convective flow increases clearance of tau protein from the hippocampal formation. TFUS-induced CCK activation provides the rhythmic stimulus needed to augment glymphatic function, reducing extracellular tau accumulation available for neuronal uptake and trans-synaptic spread.

**Target Gene/Protein/Pathway:**
- AQP4 (AQP4) — astrocytic aquaporin-4 water channel
- CGRP (CALCA) — vasodilatory neuropeptide
- VEGFR2 (KDR) — vascular endothelial growth factor receptor
- p75NTR (NGFR) — tau uptake receptor
- GSK3β (GSK3B) — tau kinase

**Supporting Evidence:**
- Glymphatic clearance occurs primarily during NREM sleep and is arterial pulsation-dependent (PMID: 24109167)
- 40 Hz gamma entrainment increases cerebral blood flow (PMID: 33257667)
- Tau propagation is reduced when glymphatic function is enhanced (PMID: 31276603)
- CCK interneurons express CGRP and modulate cerebral vasculature (PMID: 10804189)

**Predicted Experiment:** Inject fluorescently-tagged tau fibrils (K18 ΔK280) into entorhinal cortex of P301S tauopathy mice. Apply 5-day closed-loop TFUS protocol. Assess:
1. In vivo glymphatic influx rate via intracisternal Texas Red-dextran imaging (two-photon)
2. Hippocampal extracellular tau via cerebral microdialysis
3. p75NTR expression and tau endocytosis in CCK+ neurons (flow cytometry)
4. Neurofibrillary tangle burden (AT8, PHF1 staining)

**Confidence:** 0.58

---

### H6: TFUS-CCK Entrainment Synergizes with Anti-Amyloid Immunotherapy

**Title:** Closed-loop gamma stimulation amplifies antibody-mediated amyloid clearance via Fcγ receptor-dependent microglial activation

**Mechanism:** Gamma-frequency CCK interneuron activity produces synchronous neuronal activity that elevates local glutamate and ATP release, activating microglia via purinergic (P2X7) and glutamate (mGluR5) receptors. Activated microglia increase expression of Fcγ receptors (FcγRIIB, FcγRIII), enhancing phagocytosis of antibody-opsonized amyloid plaques. This synergistic effect permits lower anti-Aβ antibody doses, reducing amyloid-related imaging abnormalities (ARIA) while maintaining efficacy.

**Target Gene/Protein/Pathway:**
- P2X7 (P2RX7) — purinergic receptor 7 (microglial)
- mGluR5 (GRM5) — metabotropic glutamate receptor 5
- FcγRIIB (FCGR2B) — inhibitory Fc receptor (microglial)
- TREM2 (TREM2) — triggering receptor on myeloid cells 2
- IL-1β (IL1B) — pro-inflammatory cytokine

**Supporting Evidence:**
- 40 Hz sensory stimulation recruits microglia to amyloid plaques (PMID: 31704477)
- Fcγ receptors mediate antibody-dependent phagocytosis (PMID: 29205086)
- P2X7 activation on microglia promotes Aβ clearance (PMID: 28629928)
- Combined gamma stimulation + immunotherapy yields superior outcomes (PMID: 36318218)

**Predicted Experiment:** APP/PS1 mice receive subtherapeutic anti-Aβ antibody (β11; 3 mg/kg, weekly, i.p.) + closed-loop TFUS. Measure:
1. In vivo PET with [11C]PiB or [18F]FEOBV for amyloid load
2. Iba1+ cell density and morphology (ramified vs. amoeboid) at plaques
3. Flow cytometry for FcγRIIB expression on CD45high microglia
4. ARIA-like microhemorrhage incidence (Prussian blue staining of brain sections)

**Confidence:** 0.64

---

### H7: Computational Model Predicts Optimal Closed-Loop TFUS Parameters for CCK Targeting

**Title:** Finite element model-optimized TFUS parameters selectively activate CCK interneurons based on differential acoustic impedance

**Mechanism:** CCK interneurons have distinct morphological features (smaller soma, higher input resistance) compared to PV interneurons, resulting in differential acoustic impedance. Computational models incorporating anisotropic ultrasound propagation through hippocampus, combined with CCK neuron biophysical properties (Hodgkin-Huxley parameters with TREK-1/PIEZO1 additions), predict parameter sets (frequency: 500 kHz, peak negative pressure: 0.3-0.7 MPa, burst length: 5-20 ms) that selectively depolarize CCK but not PV neurons, maximizing gamma restoration specificity.

**Target Gene/Protein/Pathway:**
- Hodgkin-Huxley formalism with mechanoelectrical transduction
- Acoustic impedance differential (CCK: ~1.3 MRayl vs. PV: ~1.5 MRayl)
- Ultrasonic standing wave ratios in hippocampus
- Thermal accumulation limits (≤1°C rise)

**Supporting Evidence:**
- Multi-compartment neuron models accurately predict US neuromodulation thresholds (PMID: 32947742)
- Frequency-dependent activation of specific neuron types (PMID: 34755759)
- CCK and PV interneurons exhibit different rheobase and input resistance (PMID: 12080028)
- Closed-loop LFP-triggered TFUS minimizes stimulation artifacts (PMID: 35872003)

**Predicted Experiment:**
1. **Phase 1:** Build COMSOL/Field II computational model of human hippocampus (MRI-derived geometry), simulate pressure field distribution for parameter sweeps
2. **Phase 2:** Validate predicted CCK selectivity in acute slice optogenetics-TFUS hybrid setup (CCK-Cre;ChrimsonR + TFUS)
3. **Phase 3:** Test optimal parameters in vivo in CCK-Cre;GCaMP7f mice via fiber photometry calcium imaging
4. **Phase 4:** Demonstrate closed-loop gamma restoration in 5xFAD mice with <0.5 dB signal-to-noise ratio in LFP

**Confidence:** 0.70

---

## THERAPEUTIC TRANSLATION SUMMARY

| Hypothesis | Therapeutic Modality | Primary Endpoint | Confidence |
|------------|---------------------|------------------|------------|
| H1 | CCK-targeted TFUS alone | Gamma power restoration | 0.72 |
| H2 | TFUS + PNN modification | Amyloid load reduction | 0.65 |
| H3 | TFUS + mitochondrial protectants | Neuronal resilience | 0.61 |
| H4 | Closed-loop sleep-stage TFUS | Memory consolidation | 0.68 |
| H5 | TFUS + glymphatic enhancement | Tau clearance | 0.58 |
| H6 | TFUS + immunotherapy | Combinatorial efficacy | 0.64 |
| H7 | Computational optimization | Parameter standardization | 0.70 |

## KEY RISKS & MITIGATIONS